Gradishar W - Search Results

1

Randomized Phase II Study of Ramucirumab or Icrucumab in Combination with Capecitabine in Patients with Previously Treated Locally Advanced or Metastatic Breast Cancer.

Vahdat LT, Layman R, Yardley DA, Gradishar W, Salkeni MA, Joy AA, Garcia AA, Ward P, Khatcheressian J, Sparano J, Rodriguez G, Tang S, Gao L, Dalal RP, Kauh J, Miller K. Vahdat LT, et al. Among authors: gradishar w. Oncologist. 2017 Mar;22(3):245-254. doi: 10.1634/theoncologist.2016-0265. Epub 2017 Feb 20. Oncologist. 2017. PMID: 28220020 Free PMC article. Clinical Trial.

2

Phase II study of all-trans-retinoic acid and alpha-interferon in patients with advanced non-small cell lung cancer.

Athanasiadis I, Kies MS, Miller M, Ganzenko N, Joob A, Marymont M, Rademaker A, Gradishar WJ. Athanasiadis I, et al. Among authors: gradishar wj. Clin Cancer Res. 1995 Sep;1(9):973-9. Clin Cancer Res. 1995. PMID: 9816069 Clinical Trial.

3

Phase I trial of escalating doses of paclitaxel plus doxorubicin and dexrazoxane in patients with advanced breast cancer.

Sparano JA, Speyer J, Gradishar WJ, Liebes L, Sridhara R, Mendoza S, Fry D, Egorin MJ. Sparano JA, et al. Among authors: gradishar wj. J Clin Oncol. 1999 Mar;17(3):880-6. doi: 10.1200/JCO.1999.17.3.880. J Clin Oncol. 1999. PMID: 10071279 Clinical Trial.

4

Effects of high dose raloxifene in selected patients with advanced breast carcinoma.

Gradishar W, Glusman J, Lu Y, Vogel C, Cohen FJ, Sledge GW Jr. Gradishar W, et al. Cancer. 2000 May 1;88(9):2047-53. doi: 10.1002/(sici)1097-0142(20000501)88:9<2047::aid-cncr10>3.0.co;2-e. Cancer. 2000. PMID: 10813716

5

Clinical status of capecitabine in the treatment of breast cancer.

Gradishar WJ. Gradishar WJ. Oncology (Williston Park). 2001 Jan;15(1 Suppl 2):69-71; discussion 72. Oncology (Williston Park). 2001. PMID: 11219981 Free article. Review.

6

A Phase II trial of cisplatin plus WR-2721 (amifostine) for metastatic breast carcinoma: an Eastern Cooperative Oncology Group Study (E8188).

Gradishar WJ, Stephenson P, Glover DJ, Neuberg DS, Moore MR, Windschitl HE, Piel I, Abeloff MD. Gradishar WJ, et al. Cancer. 2001 Nov 15;92(10):2517-22. doi: 10.1002/1097-0142(20011115)92:10<2517::aid-cncr1602>3.0.co;2-z. Cancer. 2001. PMID: 11745184 Clinical Trial.

7

A randomized phase II pilot trial of adjuvant marimastat in patients with early-stage breast cancer.

Miller KD, Gradishar W, Schuchter L, Sparano JA, Cobleigh M, Robert N, Rasmussen H, Sledge GW. Miller KD, et al. Among authors: gradishar w. Ann Oncol. 2002 Aug;13(8):1220-4. doi: 10.1093/annonc/mdf199. Ann Oncol. 2002. PMID: 12181245 Free article. Clinical Trial.

8

Role of capecitabine (Xeloda) in breast cancer.

Kaklamani VG, Gradishar WJ. Kaklamani VG, et al. Expert Rev Anticancer Ther. 2003 Apr;3(2):137-44. doi: 10.1586/14737140.3.2.137. Expert Rev Anticancer Ther. 2003. PMID: 12722873 Review.

9

Capecitabine plus paclitaxel as front-line combination therapy for metastatic breast cancer: a multicenter phase II study.

Gradishar WJ, Meza LA, Amin B, Samid D, Hill T, Chen YM, Lower EE, Marcom PK. Gradishar WJ, et al. J Clin Oncol. 2004 Jun 15;22(12):2321-7. doi: 10.1200/JCO.2004.12.128. J Clin Oncol. 2004. PMID: 15197193 Clinical Trial.

10

Tamoxifen--what next?

Gradishar WJ. Gradishar WJ. Oncologist. 2004;9(4):378-84. doi: 10.1634/theoncologist.9-4-378. Oncologist. 2004. PMID: 15266091 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

322 results

Search Page

Filters